Followers | 3819 |
Posts | 239598 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
Thursday, January 24, 2019 1:06:47 PM
Patents http://www.fluidenergyconversion.com/technology.html
US 7,897,121 B1: Hughes Molecular Mixer and Catalytic Reactor http://www.fluidenergyconversion.com/pdfs/US7897121.pdf
DOWNLOAD LINK
US 6,865,951 B1: Adaptable Fluid Mass Flow Meter Device http://www.fluidenergyconversion.com/pdfs/AFMFMD.pdf
DOWNLOAD LINK
US 2007/0,157,738 A1: Hughes Flow Meter with Fluid Lens http://www.fluidenergyconversion.com/pdfs/FMFL.pdf
DOWNLOAD LINK
US 7,484,425 B2: Hughes Flow Meter http://www.fluidenergyconversion.com/pdfs/Patent7484425.pdf
DOWNLOAD LINK
US 6,058,787: Mass Flow Measuring Device
DOWNLOAD LINK
US 6,158,676: Micro-Atomizing Device
DOWNLOAD LINK
Lots of VYST Vystar patents
Vystar Receives 3 Patent Notices of Allowance for Vytex Latex Deproteinization
Atlanta, GA – Vystar Corp. (OTC Market: VYST) has received notice of allowance for three international patents regarding “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same” from:
1. Malaysia – (2010003317)
2. Guatemala (2010-000208) and
3. India -(2487/KOLNP/2010)
The addition of these three international patents brings the total to 14 global patents, with 10 being international and four domestic. This further expands Vystar’s patent portfolio related to its latex deproteinization process used in Vytex® natural rubber latex (NRL) which removes virtually all allergy-causing proteins from NRL, thus reducing risk of developing or experiencing allergic reactions from direct contact with latex.
“These international notices of allowance provide intellectual property (IP) protection in two of the top six latex-producing countries in the world — primary locations where we do business and are actively seeking additional manufacturing and/or processing partners for our ultra low protein Vytex raw material,” stated William Doyle, CEO of Vystar. “The claims the international patent offices are allowing will serve to further strengthen our IP around Vystar’s breakthrough deproteinization process and protect our shareholders’ investments. Also, of the top eight consumers of latex globally, Vystar now has patents in six of those countries/unions, plus applications pending in several more.”
Vystar has multiple layers of IP protection for Vytex® ultra low protein latex that extend beyond patents. Vystar controls the manufacture of the proprietary deproteinization kit that is sold to licensed Vytex producers. Producers add the kit to field latex and use standard latex manufacturing equipment with slight modifications. Vystar tests every batch of Vytex to certify that it meets the high standards of Vytex brand latex.
Removing the proteins and other non-rubbers results in the purest, cleanest, and odor-free latex that is more resilient and stronger than competitors’ lattices, offers greater tactile sensitivity and puncture/tear resistance, creates a brighter, whiter foam and offers improved clarity and color for colored latex products such as balloons.
Competitively priced against traditional latex, Vytex is a superior material for more than 40,000 applications that typically use latex or petrochemical based materials. Vytex can be used in medical gloves, catheters and devices; condoms; mattresses, toppers and pillows; cushions; balloons; adhesives; sports equipment, footwear; padding, apparel and threads.
For details on Vytex licensing, deproteinization or purchase, contact us or (866) 674-5238, x1.
Recent VYST News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM